04:08 PM EST, 02/14/2025 (MT Newswires) -- Mark Sabag, Executive Vice President, International Markets Commercial, on February 12, 2025, sold 177,626 shares in Teva Pharmaceutical Industries ( TEVA ) for $2,886,565. Following the Form 4 filing with the SEC, Sabag has control over a total of 204,964 common shares of the company, with 204,964 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/818686/000095017025021151/xslF345X05/ownership.xml